LifeStance Health Group, Inc.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
LFST$14.60+6.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except for par value)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| CURRENT ASSETS | ||
| Cash and cash equivalents | $248,642 | $154,571 |
| Patient accounts receivable, net | 95,710 | 131,802 |
| Prepaid expenses and other current assets | 71,848 | 26,137 |
| Total current assets | 416,200 | 312,510 |
| NONCURRENT ASSETS | ||
| Property and equipment, net | 161,583 | 166,041 |
| Right-of-use assets | 149,720 | 147,878 |
| Intangible assets, net | 177,665 | 190,799 |
| Goodwill | 1,293,346 | 1,293,346 |
| Other noncurrent assets | 5,419 | 7,724 |
| Total noncurrent assets | 1,787,733 | 1,805,788 |
| Total assets | $2,203,933 | $2,118,298 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $6,122 | $7,242 |
| Accrued payroll expenses | 143,327 | 117,461 |
| Other accrued expenses | 42,187 | 46,942 |
| Operating lease liabilities, current | 45,544 | 49,449 |
| Other current liabilities | 14,782 | 7,792 |
| Total current liabilities | 251,962 | 228,886 |
| NONCURRENT LIABILITIES | ||
| Long-term debt, net | 265,927 | 279,790 |
| Operating lease liabilities, noncurrent | 148,553 | 148,699 |
| Deferred tax liability, net | 16,408 | 14,329 |
| Other noncurrent liabilities | 68 | 309 |
| Total noncurrent liabilities | 430,956 | 443,127 |
| Total liabilities | $682,918 | $672,013 |
| COMMITMENTS AND CONTINGENCIES (see Note 12) | ||
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock – par value $0.01 per share; 25,000 shares authorized as of December 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | — | — |
| Common stock – par value $0.01 per share; 800,000 shares authorized as of December 31, 2025 and December 31, 2024; 388,318 and 382,735 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 3,883 | 3,827 |
| Additional paid-in capital | 2,325,758 | 2,259,818 |
| Accumulated other comprehensive income | — | 929 |
| Accumulated deficit | (808,626) | (818,289) |
| Total stockholders' equity | 1,521,015 | 1,446,285 |
| Total liabilities and stockholders’ equity | $2,203,933 | $2,118,298 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.